Literature DB >> 18451156

alpha vbeta 6 Integrin promotes the invasion of morphoeic basal cell carcinoma through stromal modulation.

Daniel Marsh1, Sarah Dickinson, Graham W Neill, John F Marshall, Ian R Hart, Gareth J Thomas.   

Abstract

Basal cell carcinoma (BCC) is the most prevalent cancer in the Western world and its incidence is increasing. The pathogenesis of BCC involves deregulated Sonic hedgehog signaling, leading to activation of the Gli transcription factors. Most BCCs have a nodular growth pattern, and are indolent, slow-growing, and considered "low-risk" lesions. In contrast, the "high-risk" morphoeic variant, which causes significant morbidity, has an infiltrative growth pattern, and is so-called because of its densely fibrous stroma. As alpha v beta 6 is capable of promoting both carcinoma invasion and fibrosis, we examined the expression of this integrin in BCCs and found that the morphoeic type showed significantly higher alpha v beta 6 expression than the nodular type (P = 0.0009). In order to examine the function of alpha v beta 6, we transfected the transcription factors Gli1 or Gli2 into NTERT, human keratinocytes to generate a BCC model. These cells expressed alpha v beta 6 and were invasive, although inhibition of alpha v beta 6 had no direct effect on cell invasion. However, the cells showed alpha v beta 6-dependent activation of transforming growth factor-beta1, which induced transdifferentiation of human fibroblasts into myofibroblasts. Paracrine secretion of hepatocyte growth factor/scatter factor by these myofibroblasts promoted c-Met-dependent tumor invasion in both Transwell and three-dimensional organotypic assays. These experimental in vitro findings were confirmed using human clinical samples in which we showed that the stroma of morphoeic BCC is myofibroblast-rich compared with nodular BCC (P = 0.0036), that myofibroblasts express hepatocyte growth factor/scatter factor, and that morphoeic BCCs are strongly c-Met-positive. These data suggest that alpha v beta 6-dependent transforming growth factor-beta1 activation induces both the infiltrative growth pattern and fibrotic stroma so characteristic of morphoeic BCC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18451156     DOI: 10.1158/0008-5472.CAN-08-0174

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  28 in total

Review 1.  Integrin-TGF-beta crosstalk in fibrosis, cancer and wound healing.

Authors:  Coert Margadant; Arnoud Sonnenberg
Journal:  EMBO Rep       Date:  2010-01-15       Impact factor: 8.807

Review 2.  Molecular imaging of integrin αvβ6 expression in living subjects.

Authors:  Hao Liu; Yue Wu; Fan Wang; Zhaofei Liu
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-06-07

3.  The Effect of Bi-Terminal PEGylation of an Integrin αvβ₆-Targeted ¹⁸F Peptide on Pharmacokinetics and Tumor Uptake.

Authors:  Sven H Hausner; Nadine Bauer; Lina Y Hu; Leah M Knight; Julie L Sutcliffe
Journal:  J Nucl Med       Date:  2015-03-26       Impact factor: 10.057

Review 4.  Integrins in cancer: biological implications and therapeutic opportunities.

Authors:  Jay S Desgrosellier; David A Cheresh
Journal:  Nat Rev Cancer       Date:  2010-01       Impact factor: 60.716

5.  TGFβ, Fibronectin and Integrin α5β1 Promote Invasion in Basal Cell Carcinoma.

Authors:  François Kuonen; Isabelle Surbeck; Kavita Y Sarin; Monique Dontenwill; Curzio Rüegg; Michel Gilliet; Anthony E Oro; Olivier Gaide
Journal:  J Invest Dermatol       Date:  2018-07-14       Impact factor: 8.551

Review 6.  Defining the role of integrin alphavbeta6 in cancer.

Authors:  A Bandyopadhyay; S Raghavan
Journal:  Curr Drug Targets       Date:  2009-07       Impact factor: 3.465

7.  Targeting αV-integrins decreased metastasis and increased survival in a nude rat breast cancer brain metastasis model.

Authors:  Y Jeffrey Wu; Leslie L Muldoon; Seymur Gahramanov; Dale F Kraemer; Deborah J Marshall; Edward A Neuwelt
Journal:  J Neurooncol       Date:  2012-07-29       Impact factor: 4.130

8.  Comparing the expression of integrins αvβ3, αvβ5, αvβ6, αvβ8, fibronectin and fibrinogen in human brain metastases and their corresponding primary tumors.

Authors:  Jens Schittenhelm; Annemarie Klein; Marcos S Tatagiba; Richard Meyermann; Falko Fend; Simon L Goodman; Bence Sipos
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

9.  Stromal control of oncogenic traits expressed in response to the overexpression of GLI2, a pleiotropic oncogene.

Authors:  A M Snijders; B Huey; S T Connelly; R Roy; R C K Jordan; B L Schmidt; D G Albertson
Journal:  Oncogene       Date:  2008-11-17       Impact factor: 9.867

Review 10.  Recent advances on skin-resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti-aging and cancer therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  J Cell Mol Med       Date:  2009-09-01       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.